Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.


SecurityAQMS / Aqua Metals, Inc. (03837J101)
President & CEOClarke Stephen R.
IndustrySecondary Smelting and Refining of Nonferrous Metals
Institutional Owners66
Institutional Shares9,740,341 - 33.95%
Common Shares Outstanding28,694,210 shares (as of 2018-03-31)
Institutional Value$ 166,861,000 USD

Institutional Stock Ownership and Shareholders()

AQMS / Aqua Metals, Inc. Institutional Ownership

Aqua Metals, Inc. (NASDAQ:AQMS) has 66 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 9,740,341 shares. Largest shareholders include AWM Investment Company, Inc., Frontier Capital Management Co Llc, BlackRock Inc., Vanguard Group Inc, Longboard Capital Advisors, LLC, Selz Capital LLC, Morgan Stanley, Millennium Management Llc, Herald Investment Management Ltd, and BlackRock Fund Advisors.
Aqua Metals, Inc. (NASDAQ:AQMS) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/aqms"><img src="https://images.fintel.io/us-aqms-so.png" alt="AQMS / Aqua Metals, Inc. Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-18 13F-HR LEVIN CAPITAL STRATEGIES, L.P. 0 55,500 0 144
2018-05-10 13F-HR AWM Investment Company, Inc. 2,405,046 1,101,467 -54.20 5,123 2,853 -44.31
2018-05-15 13F-HR GEODE CAPITAL MANAGEMENT, LLC 119,372 189,426 58.69 254 490 92.91
2018-05-15 13F-HR Ameritas Investment Partners, Inc. 838 838 0.00 2 2 0.00
2018-05-08 13F-HR FIRST MERCANTILE TRUST CO 10,098 17,113 69.47 22 44 100.00
2018-05-10 13F-HR Stratos Wealth Partners, LTD. 300 300 0.00 1 1 0.00
2018-04-30 13F-HR FRONTIER CAPITAL MANAGEMENT CO LLC 1,077,178 1,067,689 -0.88 2,294 2,765 20.53
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 4,010 152,073 3,692.34 9 393 4,266.67
2018-07-19 13F-HR David R. Rahn & Associates Inc. 16,575 48
2018-05-11 13F-HR Sigma Planning Corp 39,400 79,000 100.51 84 205 144.05
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 72,514 81,880 12.92 642 1,073 67.13
2018-05-15 13F-HR SPRINGBOK CAPITAL MANAGEMENT, LLC 107,366 48,966 -54.39 229 127 -44.54
2018-06-28 13F-HR/A BROWN ADVISORY INC 14,500 14,500 0.00 31 38 22.58
2018-05-02 13F-HR RHUMBLINE ADVISERS 15,005 15,005 0.00 32 39 21.88
2018-04-26 13F-HR SIMPLEX TRADING, LLC 5,076 11,073 118.14 10 28 180.00
2018-05-15 13F-HR BARCLAYS PLC 36,397 4,809 -86.79 78 13 -83.33
2017-02-10 13F-HR BlackRock Investment Management, LLC 39,155 39,814 1.68 347 522 50.43
2018-05-15 13F-HR TWO SIGMA INVESTMENTS LLC 37,797 0 -100.00 81 0 -100.00
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 15,482 16,956 9.52 33 44 33.33
2018-05-14 13F-HR ALLIANCEBERNSTEIN L.P. 13,500 21,200 57.04 29 55 89.66
2018-05-08 13F-HR Parallel Advisors, LLC 2,000 1,000 -50.00 4 3 -25.00
2018-05-09 13F-HR NORTHERN TRUST CORP 184,720 236,980 28.29 393 614 56.23
2018-05-11 13F-HR BNP PARIBAS ARBITRAGE, SA 3,382 41,221 1,118.84 7,204 106,762 1,381.98
2018-05-15 13F-HR Advisor Group, Inc. 650 650 0.00 1 1 0.00
2018-04-19 13F-HR Asset Dedication, LLC 1,000 1,000 0.00 2 3 50.00
2018-05-10 13F-HR JP Morgan Chase & Co 3,635 4,582 26.05 8 12 50.00
2018-05-14 13F-HR Herald Investment Management Ltd 400,000 400,000 0.00 848 1,032 21.70
2018-05-07 13F-HR AMERICAN INTERNATIONAL GROUP INC 11,350 14,545 28.15 24 38 58.33
2018-05-14 13F-HR Catamount Wealth Management 1,100 3,950 259.09 2 10 400.00
2018-05-15 13F-HR Squarepoint Ops LLC 20,200 0 -100.00 43 0 -100.00
2018-05-15 13F-HR Parallax Volatility Advisers, L.P. 2,646 11,409 331.18 6 30 400.00
2018-05-15 13F-HR MANUFACTURERS LIFE INSURANCE COMPANY, THE 3,158 93 -97.06 7 0 -100.00
2018-05-15 13F-HR DEUTSCHE BANK AG\ 426,200 30,231 -92.91 906 77 -91.50
2018-05-09 13F-HR BlackRock Inc. 891,214 907,610 1.84 1,898 2,352 23.92
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. Call 83,200 12,000 -85.58 177 31 -82.49
2018-05-11 13F-HR Cutler Group LP 4,890 2,900 -40.70 10 7 -30.00
2018-05-15 13F-HR GOLDMAN SACHS GROUP INC 10,002 17,931 79.27 21 46 119.05
2018-04-18 13F-HR REGIONS FINANCIAL CORP 70,000 70,000 0.00 149 181 21.48
2018-05-22 13F-HR/A Summit Trail Advisors, Llc 490 0 -100.00 1 0 -100.00
2018-05-18 13F-HR/A ROYAL BANK OF CANADA Call 169,000 0 -100.00 360 0 -100.00
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. Put 37,300 5,200 -86.06 79 13 -83.54
2018-05-10 13F-HR Myda Advisors Llc 15,000 0 -100.00 32 0 -100.00
2018-05-07 13F-HR SCHWAB CHARLES INVESTMENT MANAGEMENT INC 32,800 32,800 0.00 70 85 21.43
2018-05-15 13F-HR WOLVERINE TRADING, LLC Put 0 11,100 0 29
2018-05-15 13F-HR WOLVERINE TRADING, LLC 0 10,421 0 27
2018-05-07 13F-HR PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 220,920 117,781 -46.69 471 305 -35.24
2018-05-15 13F-HR UBS Group AG 25,800 53,090 105.78 55 138 150.91
2018-05-15 13F-HR WOLVERINE ASSET MANAGEMENT LLC 886,160 42,418 -95.21 1,887 109 -94.22
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ 3,000 58,500 1,850.00 8 168 2,000.00
2018-05-15 13F-HR CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 26,552 34,654 30.51 57 90 57.89
2018-04-16 13F-HR Westside Investment Management, Inc. 13,000 13,000 0.00 27,560 32,110 16.51
2018-05-10 13F-HR NEW YORK STATE COMMON RETIREMENT FUND 15,400 15,400 0.00 33 40 21.21
2018-05-15 13F-HR MILLENNIUM MANAGEMENT LLC 72,548 511,847 605.53 155 1,326 755.48
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Put 39,400 0 -100.00 84 0 -100.00
2018-07-17 13F-HR Selz Capital LLC 553,000 553,000 0.00 1,432 1,593 11.24
2017-02-10 13F-HR BlackRock Fund Advisors 291,345 344,740 18.33 2,581 4,520 75.13
2018-05-14 13F-HR Renaissance Technologies LLC 466,500 0 -100.00 994 0 -100.00
2017-02-18 SC 13G/A Longboard Capital Advisors, LLC 910,645 865,461 -4.96
2018-05-17 13F-HR Legal & General Group Plc 5,332 2,855 -46.46 11 7 -36.36
2018-07-09 13F-HR CENTRAL TRUST Co 1,000 1,000 0.00 3 3 0.00
2018-05-16 13F-HR/A GROUP ONE TRADING, L.P. 30,320 38,924 28.38 65 101 55.38
2017-02-10 13F-HR BlackRock Advisors LLC 3,024 5,627 86.08 27 74 174.07
2018-05-15 13F-HR BALYASNY ASSET MANAGEMENT LLC 44,866 0 -100.00 96 0 -100.00
2018-05-03 13F-HR MEEDER ASSET MANAGEMENT INC 600 508 -15.33 1 1 0.00
2018-05-11 13F-HR CITIGROUP INC 1,692 2,860 69.03 3 7 133.33
2018-05-15 13F-HR STATE STREET CORP 224,329 282,603 25.98 478 731 52.93
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP Call 97,800 10,500 -89.26 208 27 -87.02
2018-05-15 13F-HR WOLVERINE TRADING, LLC Call 13,400 0 -100.00 29 0 -100.00
2018-04-23 13F-HR Beech Hill Advisors, Inc. 15,925 13,925 -12.56 34 36 5.88
2018-07-13 13F-HR BANK OF MONTREAL /CAN/ Put 3,000 58,500 1,850.00 8 168 2,000.00
2018-05-15 13F-HR VANGUARD GROUP INC 828,522 896,859 8.25 1,764 2,323 31.69
2018-05-11 13F-HR MACQUARIE GROUP LTD 15,700 0 -100.00 33 0 -100.00
2018-05-14 13F-HR TEACHERS ADVISORS INC 19,580 19,580 0.00 42 51 21.43
2018-05-14 13F-HR Virtu Financial LLC 40,677 0 -100.00 87 0 -100.00
2018-05-15 13F-HR Invesco Ltd. 276,245 239,721 -13.22 588 621 5.61
2018-05-14 13F-HR PARAMETRIC PORTFOLIO ASSOCIATES LLC 21,364 77,494 262.73 46 201 336.96
2018-05-11 13F-HR Cutler Group LP Call 1,100 0 -100.00 0 0
2018-05-14 13F-HR MORGAN STANLEY 54,133 533,031 884.67 116 1,380 1,089.66
2018-05-11 13F-HR Leisure Capital Management 88,792 175,182 97.29 189 454 140.21
2018-05-15 13F-HR National Asset Management, Inc. 12,000 32
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 54,950 59,546 8.36 117 154 31.62
2018-05-15 13F-HR Bank of New York Mellon Corp 48,553 47,228 -2.73 104 122 17.31

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Related News Stories

Aqua Metals' (AQMS) Management on Q1 2018 Results - Earnings Call Transcript

2018-05-10 seekingalpha
Greetings and welcome to the Aqua Metals First Quarter 2018 Corporate Update Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. (5-2)

BRIEF-Aqua Metals And Kanen Wealth Management Reach Agreement To Strengthen Co's Board

2018-05-02 reuters
* AQUA METALS AND KANEN WEALTH MANAGEMENT REACH AGREEMENT TO STRENGTHEN COMPANY’S BOARD AND MANAGEMENT TEAM (5-0)

BRIEF-Aqua Metals Inc ‍Announces Plans for CEO Succession

2018-03-28 reuters
* AQUA METALS INC - IMPLEMENTING PLAN TO TRANSITION STEPHEN CLARKE FROM CURRENT POSITION AS PRESIDENT, CHIEF EXECUTIVE OFFICER AND CHAIRMAN OF BOARD Source text for Eikon: Further company coverage: (5-2)

Aqua Metals 2017 Q4 - Results - Earnings Call Slides

2018-03-16 seekingalpha
The following slide deck was published by Aqua Metals in conjunction with their 2017 Q4 earnings call. (5-1)

CUSIP: 03837J101